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Early diagnostics of oral malignant lesions plays 
a key role in the process of treating and evaluating 
a patient's chances of recovery – oral lesions de-
tected at an early stage, especially in the case of 
squamous cell carcinoma, markedly improve su-
rvival rates [1]. Unfortunately, two thirds of patients 
are diagnosed with oral cancer in the third or fourth 
stage of the disease's progression. The conven-
tional visual and manual examinations, supported 
by biopsy and histopathologic analysis of material, 
remains the gold standard in identifying and de-
tecting abnormalities in the oral cavity. Histological 
criteria, evaluations of dysplasia and the stage of 
the disease, make it possible to evaluate the risk of 
malignant transformations [2]. Modern diagnostic 
methods help to conduct ever more precise and 
accurate examinations. 
One of the techniques applied in the diagnos-
tics of oral mucosal lesions is their staining with 
substances which aid the diversification between 
normal and abnormal tissues. These substances 
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Wczesna diagnostyka zmian nowotworowych odgrywa kluczową rolę w przebiegu procesu leczenia oraz dalszego ro-
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chemiluminescencję z wybarwiania błękitem toluidyny), system oceny VELscope, OralCDx i biopsja szczoteczkowa. 
Zastosowanie dodatkowych technik wczesnej diagnostyki zmian w jamie ustnej może być pomocne dla każdego le-
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Abstract
Early diagnostics of oral cancerous lesions plays a crucial role in the process of treatment and evaluation of the pa-
tient's chances for recovery. The article presents new techniques of identifying and detecting abnormal lesions within 
oral mucosa, such as oral lumenoscopy (ViziLite), TBlue (toluidine blue marking system), VELscope screening system, 
OralCDx and the brush biopsy. Their application does not allow a definite diagnosis, nor does it replace biopsy or his-
topathologic assessment, but it permits a more accurate examination of the oral cavity, as well as oral lesion detection 
at the early stage of progression. 
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include 3% Lugol's solution, which works by bind-
ing compounds of iodine with glycogen found in cy-
toplasm, simultaneously marking the tissue brown 
[3]. The cancerous cells, which are distinguished 
by an increased activity of glycolysis do not be-
come stained; in contrast to the mucus membrane 
of healthy tissue, which changes colour [4]. Many 
publications extensively describe the method of 
toluidine blue (TB) application. It is an organic sub-
stance used for the vital staining of tissues. It binds 
with the DNA of the cells which are subject to inten-
sive division (during inflammation or regeneration 
processes), or whose genetic material is damaged 
[5, 6]. The compound was originally applied in order 
to aid the detection of oral epithelial dysplasia, and 
currently it is also used in detecting areas particu-
larly at risk of a malignant transformation, as well 
as indicating the best possible site in the oral cavity 
to obtain a tissue sample for biopsy – the tissue 
sample is obtained from the most stained areas. 
Toluidine blue is characterized by high sensitivity; 
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however, it seems to have low specificity – both the 
benign and inflammatory lesions become stained 
[7]. Research publications present various methods 
of TBlue application – in the form of a topical appli-
cation or as an irrigant. Apart from single applica-
tions, in order to eliminate the false-positive results 
mentioned above, double staining is performed – 
by repeating the decolourisation procedure during 
the follow-up appointment which takes place ap-
proximately two weeks later [8]. Such a course of 
action is recommended by Mashberg [9] – before 
the follow-up visit it is advisable to eliminate all ir-
ritating and inflammatory factors which may lead to 
the false-positive results associated with staining 
such areas by the use of a toluidine blue solution. 
The sensitivity in respect of detecting the lesions 
through TBlue application varies, depending on the 
researcher, between 38–98% (on average 85%), 
and in the case of specificity between 22–92% (on 
average 67%). Onfre et al. consider the described 
method as trustworthy in oral cancer detection, 
whether invasive or in situ [10]. 
Another method used in oral cancer diagno-
stics is chemiluminescence – with the application 
of commercially available ViziLite Plus together 
with the TBlue marking system this combines the 
advantages of chemiluminescence and toluidine 
blue staining. The ViziLite system consists of two 
components: a 1% solution of acetic acid with a ra-
spberry flavour which removes the layer of glyco-
protein from the surface of the mucus membrane 
in order to decrease the light reflection and desic-
cates the cells to increase the nucleus-cytoplasm 
ratio; the other component being a retractor emit-
ting light for over 10 minutes after its activation 
with an emission wavelength of 430–580 nm, 
which enables a precise examination of oral tissu-
es. The retractor constitutes a disposable device. 
The blue light of ViziLite becomes absorbed by he-
althy cells and reflected by the cells with abnormal 
keratin production. Lesions detected by means of 
this technique then become stained by the use of 
TBlue system. The TBlue marking system includes 
three swab components – the first swab, used for 
initial application, is saturated with a 1% solution 
of acetic acid; the second one contains a 0.5% 
solution of toluidine blue; and the last component 
– a 1% acetic acid solution swab – is used after 
the dye application. The oral mucosal abnormali-
ties identified during the ViziLite examination have 
their brightness increased, and are more distinctly 
demarcated compared to lesions examined using 
conventional dental illumination [8]. It was also de-
monstrated that the outlines of the examined le-
sions are sharper than of those detected during 
conventional examination [11].
Considering the advantages of applying the 
presented methods, one must bear in mind that 
they still have only an auxiliary function. The draw-
backs of ViziLite examinations include the dispos-
able retractors and hence increased costs of the 
method's application, as well as the impossibility of 
determining the character of a lesion at this stage 
of examination. The study conducted by Kerra et 
al. demonstrated that some of the red lesions, 
which are often associated with dysplasia, were 
not detected by a ViziLite examination [12]. By stat-
ing that the application of the VisiLite system im-
proves the effectiveness of white lesion detection, 
Epstein et al. [13] have recognized the usefulness 
of chemiluminescence in the diagnostics of early 
malignant lesions in the oral cavity [14]. Other re-
searchers share the view that the application of 
the diagnostic methods described above enables 
a detection of lesions that are invisible when ex-
amined under conventional dental illumination [15]. 
This opinion is also supported by the statement 
that TBlue application decreases the false-positive 
results by 55.26%, without increasing the percent-
age of false-negative results [16].
In general, from the quoted assessments made 
by experienced specialists, it can be concluded 
that the application of the ViziLite system, owing to 
its ability to enhance lesion brightness and sharp-
ness, may aid general dentists in the performance 
of screening tests. 
Another well-known system used for oral mu-
cosal lesion detection is the VELscope screening 
system. Its action is based on the disturbed fluo-
rescence of pathological tissues, which are char-
acterized by a modified fluorophore system [17]. 
Tissue fluorescence depends on the structural 
changes which it undergoes, the metabolic activ-
ity, the presence of haemoglobin, the blood ves-
sel condition, as well as the possible presence of 
inflammation. In the light emitted at a wavelength 
of 400–460 nm healthy tissues are illuminated in 
green, whereas abnormal lesions are coloured be-
tween brown and black. This technique is of great 
assistance in lesion detection; however, it does not 
make it possible to differentiate between benign 
and malignant lesions [18]. According to Poh et al., 
the application of this lesion identification system 
may become useful in demarcating the boundaries 
of a malignant lesion [19]. Moreover, they empha-
size the considerable costs of colour interpreta-
tion and the difficulties in its performance, which 
may result in diagnostic errors [20]. Balevi et al. 
recommend the use of the VELscope system only 
in specialized medical clinics. [21]. The sensitivity 
of this method is evaluated as ranging between 
98–100%, whereas its specificity is estimated at 
94–100% [22]. 
Other systems using light emission for lesion 
detection include the Microlux DL system. The 
source of light, which is powered by batteries, is 
reusable – it can be sterilized. According to the 
recommendations of the Microlux DL producer, it 
helps in the detection of pathological tissues and 
should be used together with conventional exa-
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mination [22]. The patient rinses the oral cavity 
with acetic acid to remove the glycoprotein layer 
and hence to improve the light penetration. Corre-
spondingly to the previous solutions, it is impossi-
ble to differentiate between benign and malignant 
lesions; however, the visibility of lesions and their 
visual separation become enhanced.
The Orascoptic DK constitutes a similar lesion 
identification system, where after the oral rinse with 
a mild acetic acid solution the oral mucosa is illumi-
nated by an LED diode powered by batteries [23].
The brush biopsy makes it possible to obtain 
a tissue sample for biopsy with minimal tissue inva-
sion; intrasurgical bleeding is kept to a minimum, 
the risk of complications is low [24], and the wait-
ing period for results is not long. Nevertheless, 
the method itself has some drawbacks. Unless all 
epithelial layers, together with the basement mem-
brane, are taken, there is a considerable risk of 
false-positive results in the order of 37% [25]. The 
OralCDx Brush Test helps to eliminate diagnostic 
errors. In order to obtain a tissue sample a spe-
cial kit is used, which comprises a brush, a micro-
scopic slide, and a bag with a fixing solution (pro-
pylene glycol), as well as an information sheet and 
a plastic container to ensure dry transportation. 
The collection of oral mucosal cells is performed 
with a wet brush, until bleeding spots on the mu-
cus membrane occur [26]. The dentist spreads the 
obtained material on a microscopic slide, and then 
fixes it. After staining is performed through the use 
of the modified Papanicolau method, the obtained 
tissue sample is analysed under the microscope 
with the aid of a computer-assisted screening sys-
tem [27, 12]. It evaluates the shape and size of the 
cells. This becomes the basis for describing the 
sample as "negative" or the lesion "benign"; "posi-
tive" – including cancerous lesions and dysplasia; 
as well as "atypical" – encompassing atypical epi-
thelial lesions with an unclear diagnostic mean-
ing or impossible to assess due to the scarcity of 
epithelial layers [28]. After the introductory assess-
ment the result is interpreted by a histopathologist. 
A positive result requires obtaining a tissue sample 
in a conventional way in order to continue the diag-
nostics procedure. Thus, the ORalCDx Brush Test 
system is only applied in the case of small-sized 
mucosal lesions, when obtaining a typical tissue 
sample is not a procedural option [23]. According to 
research publications, the sensitivity of this meth-
od, depending on the chosen technique of sensitiv-
ity analysis, varies between 88% and 100%, and 
the specificity ranges between 25% and 96% [4]. In 
their research Acha et al. [29] and Driemel et al. [30] 
regard as one of the additional advantages of the 
Oral CDx system the possibility of an additional cy-
tomorphometrical and molecular analysis. Sciubba 
et al. [26], Christian et al. [31] and Scheifele et al. 
[32] recommend the application of the Oral CDx 
system as a screening technique for the detection 
of malignant lesions in the oral cavity. 
The emergence of new techniques for abnor-
mal lesion identification and detection, indicated 
in the article, has expanded and enhanced the set 
of diagnostic methods that are available to denti-
sts for the early detection of oral mucosal lesions. 
The application of these methods often does not 
make it possible to expressly determine a lesion's 
character, hence they cannot replace biopsy or hi-
stopathologic diagnostics. However, they provide 
invaluable help with regard to examining the oral 
cavity with more precision, and the possibility of 
detecting oral mucosal lesions at an early stage of 
progression.
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